TD Cowen Maintains Outperform on Privia Health Gr, Lowers Price Target to $35
Portfolio Pulse from jenniferd'souza@benzinga.com
TD Cowen analyst Gary Taylor has maintained an 'Outperform' rating on Privia Health Gr (NASDAQ:PRVA), but lowered the price target from $44 to $35.

August 15, 2023 | 12:22 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
TD Cowen has maintained an 'Outperform' rating on Privia Health Gr but lowered the price target from $44 to $35.
The news is directly related to Privia Health Gr (PRVA). The 'Outperform' rating suggests that the analyst expects the stock to do better than the market average. However, the lowering of the price target from $44 to $35 might create a negative sentiment among investors, potentially putting downward pressure on the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100